gastroenterology

AzurRx completes enrollment in Phase 2 clinical trial of MS1819 in combination with PERT to treat cystic fibrosis patients with severe exocrine pancreatic insufficiency

Progenity presents results on PIL Dx capsule in small intestinal bacterial overgrowth